CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Pangali Sanam Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 36,000 | ||
| 2026-06-30 | TETRAULT LYNN A. Director | Grant or award | +3,553 | 3,553 | ||
| 2026-06-30 | TETRAULT LYNN A. Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2026-06-30 | Srivastava Sapna Director | Grant or award | +3,553 | 3,553 | ||
| 2026-06-30 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2026-06-30 | Yao Zhengbin Director | Grant or award | +3,553 | 27,082 | ||
| 2026-06-30 | Yao Zhengbin Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2026-06-30 | Machado Patrick Director | Grant or award | +3,553 | 3,553 | ||
| 2026-06-30 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2026-06-30 | AKKARAJU SRINIVAS Director | Grant or award | +3,553 | 3,553 | ||
| 2026-06-30 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2026-05-22 | Drappa Jorn Chief Medical Officer | Option exercise | +11,317 | $8.84 | $100K | 43,804 |
| 2026-05-22 | Drappa Jorn Chief Medical Officer | Option exercise | +15,535 | $5.06 | $79K | 59,339 |
| 2026-05-22 | Drappa Jorn Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −11,317 | 159,805 | ||
| 2026-05-22 | Drappa Jorn Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −15,535 | 164,465 | ||
| 2026-04-01 | Foresite Labs, LLC 10% owner | Other disposition | −1,176,470 | 0 | ||
| 2026-04-01 | Foresite Labs, LLC 10% owner | Other acquisition | +1,123,337 | 1,123,337 | ||
| 2026-04-01 | Foresite Labs, LLC 10% owner | Other disposition | −1,123,337 | 0 | ||
| 2026-04-01 | Foresite Labs, LLC 10% owner | Other acquisition | +680,486 | 680,486 | ||
| 2026-04-01 | Foresite Capital Management VI LLC 10% owner | Other disposition | −1,176,470 | 0 |
Page 2 of 21 · 405 trades